Last reviewed · How we verify
Development of an International COVID-19 Specific Quality of Life Questionnaire, Phase III. The OSLO COVID-19 QLQ
Purpose: to develop an international validated patient-reported outcome measure for COVID-19 patients according to international guidelines. In this phase III of the project, the preliminary questionnaire of 80 items will be tested. It has been developed based on literature review and interviews with health care professionals and patients (phase I-II). In Phase III A patients will fill in the questionnaire followed by interviews on relevance, importance and wording of the questionnaire In Phase III B patients will fill in the questionnaire and an debriefing questionnaire. We will do explorative psychometric analyses.
Details
| Lead sponsor | Oslo University Hospital |
|---|---|
| Status | COMPLETED |
| Enrolment | 371 |
| Start date | Fri Nov 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Thu Sep 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Covid19, Patient Reported Outcome Measures, Quality of Life
Interventions
- No intervention. Method study. Psychometric testing
Countries
Norway